Peter Traber, President & CEO at Galectin Therapeutics, holds 451.83K shares in Cartesian Therapeutics (Ticker: RNAC), holds 149.19K shares in Lisata Therapeutics (Ticker: LSTA), holds 107.33K shares in Galectin Therapeutics (Ticker: GALT). Most recently, Peter Traber Sold ― shares of Cartesian Therapeutics on Sep 26, 2023 for an estimated value of 747.30.